InMed Pharmaceuticals Inc.: Form 8-K, filed Mar 6, 2026
Filed with the SEC on Mar 6, 2026 and accepted by EDGAR at Mar 6, 2026, 16:58 ET.
Items reported
- Item 2.05 Exit or disposal costs
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-024752. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.